Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2013

May 8, 2013

35124_dirs_2013-05-08_703336a8-cd78-43d7-8e58-90271e72ea66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2013-05-06

Reporting Person: Fritz Frederick J. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-06 Option to Purchase Celsion Corporation Common Stock $0.97 A 35000 Acquired 2023-05-06 Celsion Corporation Common Stock (35000) Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The option vests in thirds on May 6, 2013, May 6, 2014 and May 6, 2015.